$0.01
(Market cap
$2,130 Mln
Revenue (TTM)
$1,951 Mln
P/E Ratio
12.5
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$105 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
33.81
-
EV/EBITDA
8.3
-
Debt to Equity
0.5
-
Book Value
$--
-
EPS
$2.1
-
Face value
--
-
Shares outstanding
81,253,271
10 Years Aggregate
CFO
$2,968.68 Mln
EBITDA
$4,380.32 Mln
Net Profit
$544.73 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mednax Inc (MD)
| 25.7 | 2.4 | 23.1 | 61.9 | 24.4 | -2.8 | -8.7 |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Mednax Inc (MD)
| 63.0 | 40.7 | -37.4 | -45.4 | 10.9 | -11.7 | -15.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mednax Inc (MD)
|
26.9 | 2,130.5 | 1,950.6 | 174.8 | 12.5 | 20 | 12.5 | 2.4 |
| 522.8 | 7,065.2 | 2,595.0 | 275.0 | 14.1 | 30.4 | 26.9 | 8.4 | |
| 122.1 | 11,869.0 | 6,206.1 | 621.0 | 18.6 | 16.2 | 20.2 | 4.6 | |
| 27.5 | 7,433.4 | 2,578.1 | -142.0 | -6.3 | -32.8 | -- | 22.4 | |
| 12.7 | 4,703.1 | 1,584.8 | 50.6 | 4.9 | 3.4 | 94.7 | 3.2 | |
| 219.0 | 3,707.8 | 1,559.0 | 140.3 | 12.1 | 12.6 | 26.3 | 3.3 | |
| 24.2 | 3,579.9 | 5,693.5 | 209.6 | 6.0 | 16.2 | 18.1 | 2.8 | |
| 74.1 | 5,871.6 | 2,268.9 | -21.1 | 4.7 | -4.5 | -- | 5.4 | |
| 19.0 | 5,499.2 | 1,216.2 | 163.5 | 33.5 | 25.7 | 33.8 | 8.4 | |
| 171.2 | 10,081.7 | 5,486.7 | 378.7 | 9.2 | 16.2 | 27.1 | 4.1 |
Shareholding Pattern
View DetailsAbout Mednax Inc (MD)
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications... within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Read more
-
CEO & Director
Dr. James D. Swift M.D.
-
CEO & Director
Dr. James D. Swift M.D.
-
Headquarters
Sunrise, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Mednax Inc (MD)
What is the current share price of Mednax Inc (MD) Today?
The share price of Mednax Inc (MD) is $26.89 (NYSE) as of 04-Sep-2026 13:38 EDT. Mednax Inc (MD) has given a return of 24.39% in the last 3 years.
What is the current PB & PE ratio of Mednax Inc (MD)?
The P/E ratio of Mednax Inc (MD) is 12.55 times as on 21-Aug-2026, a 63 discount to its peers’ median range of 33.81 times.
The P/B ratio of Mednax Inc (MD) is 2.42 times as on 21-Aug-2026, a 32 discount to its peers’ median range of 3.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
10.92 |
2.09 |
2024 |
-11.37 |
1.47 |
2023 |
-12.93 |
0.92 |
2022 |
18.58 |
1.38 |
2021 |
17.96 |
2.62 |
What is the 52 Week High and Low of Mednax Inc (MD)?
The 52-week high and low of Mednax Inc (MD) are Rs 27.94 and Rs 15.70 as of 05-Sep-2026.
What is the market cap of Mednax Inc (MD)?
Mednax Inc (MD) has a market capitalisation of $ 2,130 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Mednax Inc (MD)?
Before investing in Mednax Inc (MD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.